Thiocyanic Acid

Thiocyanic Acid

SCHEMBL392288

CCCCn1cc[n+](C)c1.N#C[S-]

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.67
HSP90AA1 P07900 2/20 0.67
KMT2A Q03164 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
APAF1 O14727 1/20 0.67
NPC1 O15118 1/20 0.67
PLA2G1B P04054 1/20 0.67
MAPT P10636 1/20 0.67
MAPK1 P28482 1/20 0.67
HTT P42858 1/20 0.67
RAB9A P51151 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67
ATG4B Q9Y4P1 1/20 0.67
FDPS P14324 16/20 0.37
PON1 P27169 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiocyanic Acid SCHEMBL15008519 0.95 MEN1 (0.75) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Thiocyanic Acid SCHEMBL666454 0.93 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Thiocyanic Acid SCHEMBL15008724 0.93 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Thiocyanic Acid SCHEMBL15008561 0.93 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Thiocyanic Acid SCHEMBL2125778 0.93 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Thiocyanic Acid SCHEMBL15009008 0.93 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Thiocyanic Acid SCHEMBL2125982 0.93 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Thiocyanic Acid SCHEMBL666009 0.93 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Thiocyanic Acid SCHEMBL2124101 0.93 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL30488990 0.91 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 938 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026099153-A1 DEVICE CAPABLE OF BONDING AND DEBONDING ON DEMAND TESA SE (DE) 2026-05-15 WO claimed
EP-4703496-A1 ETCHING COMPOSITION COMPRISING AT LEAST ONE IONIC LIQUID AND AT LEAST ONE LACTAMIDE AND PROCESS FOR COATING PLASTIC SURFACES WITH METALS BY USING THE SAME BASF SE (DE) 2026-03-04 EP claimed
US-20250382408-A1 EPOXY-TERMINATED ISOCYANATE PREPOLYMERS, AND PROCESS FOR THE PREPARATION THEREOF BASF SE (DE) 2025-12-18 US claimed
EP-4617650-A1 FLEXIBLE ELECTROLYTE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Zhengzhou Winsen Electronics Technology Co., Ltd (CN) 2025-09-17 EP claimed
US-20250286118-A1 Anodeless Solid-State Lithium Metal Batteries and Manufacturing Method HONEYCOMB BATTERY COMPANY (US) 2025-09-11 US claimed
EP-3275039-B1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF CORP (US) 2025-08-27 EP claimed
US-20250140940-A1 Flame-Resistant Solid-State Batteries and Manufacturing Method HONEYCOMB BATTERY COMPANY (US) 2025-05-01 US claimed
EP-4543955-A1 EPOXY-TERMINATED ISOCYANATE PREPOLYMERS, AND PROCESS FOR THE PREPARATION THEREOF BASF SE (DE) 2025-04-30 EP claimed
CN-119823109-A An electrochromic material electrochromic composition and electrochromic device 吉林大学 2025-04-15 CN claimed
CN-119403855-A Epoxy blocked isocyanate prepolymer and method for producing same 巴斯夫欧洲公司 2025-02-07 CN claimed
US-20090289214-A1 MAGNETORHEOLOGICAL FORMULATION BASF SE (DE) 2009-11-26 US claimed
EP-2067147-A1 MAGNETORHEOLOGICAL FORMULATION BASF SE (DE) 2009-06-10 EP claimed
EP-1984438-A1 ANTISTATIC POLYURETHANE BASF SE (DE) 2008-10-29 EP claimed
US-20080166243-A1 Liquid for Compressing a Gaseous Medium and Use of the Same LINDE AG (DE) 2008-07-10 US claimed
WO-2008034820-A1 MAGNETORHEOLOGICAL FORMULATION BASF SE (DE) 2008-03-27 WO claimed
EP-1877668-A1 LIQUID FOR COMPRESSING A GASEOUS MEDIUM AND USE OF THE SAME Linde AG (DE) 2008-01-16 EP claimed
WO-2007090755-A1 ANTISTATIC POLYURETHANE BASF AKTIENGESELLSCHAFT (DE) 2007-08-16 WO claimed
WO-2006120145-A1 LIQUID FOR COMPRESSING A GASEOUS MEDIUM AND USE OF THE SAME LINDE AG (DE) 2006-11-16 WO claimed
WO-2006077082-A1 METHOD FOR SEALING ROTATING SHAFTS BASF AKTIENGESELLSCHAFT (DE) 2006-07-27 WO claimed
EP-1512460-A1 Preparation and use of ionic liquids having thiocyanat as anion Solvent Innovation GmbH (DE) 2005-03-09 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166243-A1 Liquid for Compressing a Gaseous Medium and Use of the Same PIEZO1, SHH, CFD MEN1 53/4885HSP90AA1 794/4885KMT2A 3724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.